Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001628280-26-000966 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-06 | 2026-01-02 | PCRX | Lee Frank D. | CEO, Dir | F - Tax | $24.46 | -9,272 | 440.5K | -2% | -$226.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | F | D | 9,272 | $24.46 | 440,500.84 | D | — | — | (F1) Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. (F2) Includes 1,363.841 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025. |